RETRACTED: Recent advances in cardiac regeneration: Stem cell, biomaterial and growth factors

Mostafa Cheraghi1, Mehrdad Namdari1, Babak Negahdari2

  • 1Department of Cardiology, Lorestan University of Medical Sciences, Khoramabad, Iran.

Insights

This review explores advances in cardiac regeneration after myocardial infarction, focusing on stem cells, biomaterials, and growth factors to improve treatment efficacy and patient outcomes.

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Biomaterials Science

Background:

  • Myocardial infarction causes millions of global deaths annually, with current treatments offering palliative rather than curative solutions.
  • Limited protein/cell therapy half-life and low transplanted cell survival hinder effective cardiac regeneration post-myocardial infarction.

Purpose of the Study:

  • To review recent advancements in cardiac regeneration strategies.
  • To focus on the synergistic roles of stem cells, biomaterials, and growth factors in treating myocardial infarction.

Main Methods:

  • Literature review of recent studies on cardiac regeneration.
  • Analysis of stem cell therapies, biomaterial delivery systems, and growth factor applications.
  • Discussion of challenges and future directions in the field.

Main Results:

  • Stem cells show promise in regenerating cardiac tissue after myocardial infarction.
  • Biomaterial delivery systems and growth factors are being developed to overcome limitations of traditional therapies.
  • Novel approaches aim to enhance transplanted cell survival and therapeutic efficacy.

Conclusions:

  • Combining stem cells, biomaterials, and growth factors offers a promising therapeutic avenue for myocardial infarction.
  • Further research is needed to optimize these strategies for clinical application.
  • Regenerative medicine holds potential for curative treatments for heart damage.